LIOTTA DENNIS C has a total of 12 patent applications. Its first patent ever was published in 2001. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and measurement are CONGENIA S R L, MATRIX LAB LTD and ROUSSEL MAESTRETTI SPA.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 2 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Acyclic or carbocyclic compounds | |
#4 | Medical preparations | |
#5 | Sugars | |
#6 | Analysing materials | |
#7 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Liotta Dennis C | 12 |
#2 | Snyder James P | 6 |
#3 | Traynelis Stephen F | 3 |
#4 | Dingledine Raymond J | 3 |
#5 | Mosley Cara | 2 |
#6 | Tahirovic Yesim Altas | 2 |
#7 | Wilson Lawrence | 2 |
#8 | Zhan Weiqiang | 2 |
#9 | Schinazi Raymond F | 2 |
#10 | Kroll Sebastian H B | 1 |
Publication | Filing date | Title |
---|---|---|
US2012041198A1 | Process for preparing 5,7 diaminopyrazolo [1,5-A] pyrimidine compounds | |
US2010272648A1 | Methods of Identifying Improved NMDA Receptor Antagonists | |
WO2009089285A2 | Branched diepoxide compounds for the treatment of inflammatory disorders | |
US2008227799A1 | CXCR4 Antagonists Including Heteroatoms for the Treatment of Medical Disorders |